… MR-proADM improved the mortality risk stratification in patients with infection presenting
to the ED beyond SOFA score alone and may further improve initial therapeutic site-of-care …

… surgery, preoperative levels of MR-proADM and CT-proET-1 are predictors of 30-day mortality
and could improve the … It might be an additional tool for more accurate risk stratification. …

… 20 Csordas A, Nietlispach F, Schuetz P, et al: Midregional proadrenomedullin improves
risk stratification beyond surgical risk scores in patients undergoing transcatheter aortic valve …

… There is indeed evidence to suggest that a multimarker approach improves risk stratification
… better risk prediction. Our findings should also be independently validated in larger cohorts. …

… The exponential increase in the number of patients with severe COVID-19, including those
… In this regard, risk stratification is critical, allowing the choice of the most appropriate level of …

… Biomarkers may improve the predictive accuracy of risk scores for major postoperative …
-based medicine; they improve therapeutic effectiveness and increase the likelihood of achieving …

… Since a clinically important proportion of these patients do deteriorate unexpectedly, improved
risk stratification would be useful. Mid-regional pro-adrenomedullin (MR-proADM) is one …

… , offering promise for improved risk assessment and treatment … potential value in risk
stratification and informed therapeutic … a superior prognostic value beyond the initial year following …

… of these hormones could improve presurgical risk stratification in patients with PPGL. If so, …
in order to assess the risk of blood pressure fluctuations during PPGL surgery. In addition, we …

… improve the ability to predict complications, allowing for precise and dynamic risk stratification
… The use of mid-regional proadrenomedullin to identify disease severity and treatment …